The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment

This study has been completed.

Sponsor:

Collaborator:

AstraZeneca

Information provided by (Responsible Party):

University of Minnesota - Clinical and Translational Science Institute

ClinicalTrials.gov Identifier:

NCT00407199

First received: November 30, 2006

Last updated: October 26, 2011

Last verified: October 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2007
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)

Publications: